In this episode of the Oliver Wyman Health Podcast, we're live from London to talk UK healthcare's advancements in technology, and cracking brain cancer.
Oliver Wyman Actuarial Consulting analyzes what happens after manufacturer costs for brand drugs change hands.
We reviewed the approaches State legislators took to offset the effect of defunding CSRs. Here are our observations of activity across the country.
The future of medicine is bright, as opportunities from companies like Apple may soon overhaul the industry. But is true patient empowerment a realistic expectation?
Blockchain’s impact on healthcare interoperability is unknown. But those healthcare leaders who understand blockchain's technical merits will stay relevant tomorrow.
High medical trend rates continue to impact Chinese employees. Learn why Chinese employers should develop sound investment strategies around cost drivers.
The Middle East is working to redefine its healthcare system amidst governmental regulation. Here are four key trends for a market on the leading edge of innovation.
Why are premiums rising amidst the Affordable Care Act market? It's not because of medical trends, says Oliver Wyman's 2018 Carrier Trend Survey.
Here’s more on how proposed modifications to CMS’ Advance Notice Summary may affect reimbursement, payment growth rates, and regulation.
Here are some greater implications and carrier considerations regarding draft regulation changes for association health plans.
